Literature DB >> 26477945

Accumulation of reactivity to MBP sensitizes TRAIL mediated oligodendrocyte apoptosis in adult sub cortical white matter in a model for human multiple sclerosis.

Sajad Mir1,2, Farrah Ali3, Deepika Chauhan3, Rajesh Arora4, Haider A Khan5.   

Abstract

Reactivity to myelin associated proteins is the hallmark of human multiple sclerosis (M.S) and its experimental counterparts. However, the nature of such reactivity has not been described fully. Herein, we report that myelin basic protein (MBP) reactivity accumulates in a rat model for M.S. over a period of time and sensitizes TRAIL mediated progressive oligodendrocyte apoptosis. We used active immunization by Myelin Oligodendrocyte Glycoprotein (MOG, 50 μg) to study chronic remitting relapsing encephalomyelitis in rats. A time point analysis of the progressive disease revealed cumulative accumulation of anti myelin basic protein antibodies during the disease progression with minimal change in the anti-MOG antibodies. Increased reactivity to MBP was studied to sensitize TNF related apoptosis-inducing ligand (TRAIL) and other proinflammatory cytokines in a cumulative fashion leading to the Caspase dependent apoptosis of oligodendrocytes and myelin loss. In a rescue experiment, we could limit the demyelination and prevent disease progression by neutralizing the effector, TRAIL in an early stage of the disease. This is the first study to identify the accumulation of MBP antibodies in MOG induced EAE which possibly leads to TRAIL sensitized oligodendrocyte apoptosis in the white mater of EAE rats. This finding stresses on the need to study MBP antibody titers in M.S. patients and therefore might serve as an alternate marker for progressive demyelination.

Entities:  

Keywords:  Demyelination; EAE; MBP; Multiple sclerosis, autoimmunity, neuroinflammation; Trail

Mesh:

Substances:

Year:  2015        PMID: 26477945     DOI: 10.1007/s11011-015-9750-5

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  28 in total

1.  Age-dependent accumulation of ubiquitinated 2',3'-cyclic nucleotide 3'-phosphodiesterase in myelin lipid rafts.

Authors:  Jason D Hinman; Ci-Di Chen; Sun-Young Oh; William Hollander; Carmela R Abraham
Journal:  Glia       Date:  2008-01-01       Impact factor: 7.452

Review 2.  Identification and development of new therapeutics for multiple sclerosis.

Authors:  Ralf A Linker; Bernd C Kieseier; Ralf Gold
Journal:  Trends Pharmacol Sci       Date:  2008-09-17       Impact factor: 14.819

3.  2',3'-Cyclic nucleotide 3'-phosphodiesterase: a membrane-bound, microtubule-associated protein and membrane anchor for tubulin.

Authors:  Maurizio Bifulco; Chiara Laezza; Stefania Stingo; J Wolff
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-12       Impact factor: 11.205

Review 4.  Pathology of multiple sclerosis and related inflammatory demyelinating diseases.

Authors:  Alexandra Kutzelnigg; Hans Lassmann
Journal:  Handb Clin Neurol       Date:  2014

5.  Increased spontaneous apoptosis of rat primary neurospheres in vitro after experimental autoimmune encephalomyelitis.

Authors:  Mir Sajad; Jamil Zargan; Jyoti Sharma; Raman Chawla; Rajesh Arora; Sadiq Umar; Haider A Khan
Journal:  Neurochem Res       Date:  2011-03-30       Impact factor: 3.996

6.  Blocking initial infiltration of pioneer CD8(+) T-cells into the CNS via inhibition of SHP-2 ameliorates experimental autoimmune encephalomyelitis in mice.

Authors:  Qiong Luo; Yang Sun; Fang-Yuan Gong; Wen Liu; Wei Zheng; Yan Shen; Zi-Chun Hua; Qiang Xu
Journal:  Br J Pharmacol       Date:  2014-04       Impact factor: 8.739

Review 7.  Progressive multiple sclerosis: pathology and pathogenesis.

Authors:  Hans Lassmann; Jack van Horssen; Don Mahad
Journal:  Nat Rev Neurol       Date:  2012-09-25       Impact factor: 42.937

8.  Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue.

Authors:  K D McCarthy; J de Vellis
Journal:  J Cell Biol       Date:  1980-06       Impact factor: 10.539

Review 9.  Demyelination in multiple sclerosis.

Authors:  Catherine Lubetzki; Bruno Stankoff
Journal:  Handb Clin Neurol       Date:  2014

10.  Emergence of three myelin proteins in oligodendrocytes cultured without neurons.

Authors:  M Dubois-Dalcq; T Behar; L Hudson; R A Lazzarini
Journal:  J Cell Biol       Date:  1986-02       Impact factor: 10.539

View more
  3 in total

Review 1.  Insight into the divergent role of TRAIL in non-neoplastic neurological diseases.

Authors:  Shiqi Gao; Yuanjian Fang; Sheng Tu; Huaijun Chen; Anwen Shao
Journal:  J Cell Mol Med       Date:  2020-08-22       Impact factor: 5.310

2.  Claudin-1 and Claudin-3 as Molecular Regulators of Myelination in Leukoaraiosis Patients.

Authors:  Yan Chen; Zheng Zheng; Ainong Mei; Huan Huang; Fan Lin
Journal:  Clinics (Sao Paulo)       Date:  2021-05-17       Impact factor: 2.365

3.  Correlation between antibodies to bisphenol A, its target enzyme protein disulfide isomerase and antibodies to neuron-specific antigens.

Authors:  Datis Kharrazian; Aristo Vojdani
Journal:  J Appl Toxicol       Date:  2016-09-09       Impact factor: 3.446

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.